We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App





Nikon Instruments Displays Latest Clinical Pathology Products at AACC 2022

By LabMedica International staff writers
Posted on 27 Jul 2022

Nikon Instruments (Melville, NY, USA) will be displaying its latest clinical pathology products, including digital pathology and remote slide viewing and sharing, at the 2022 AACC Clinical Lab Expo. More...



The Nikon exhibit booth will feature ECLIPSE Ci-E upright microscope with Digital Sight 10 camera alongside the ECLIPSE Ci-L plus upright microscope with DS-Fi3 camera and NIS-Elements L tablet. To meet the demands of clinical laboratory specialists and researchers, Nikon has reviewed all aspects of microscope usability to develop the ECLIPSE Ci series of microscopes, which combines superior functionality with operational ease. The Ci is designed to ensure natural posture while viewing images, sample changing and capturing images. Bright, eco-friendly LED illumination reduces the need for frequent lamp replacement. A variety of accessories are available that support various imaging techniques.

At AACC 2022, Nikon will showcase the NIS-Elements D imaging software and NIS-Elements BR imaging software. The NIS-Elements D software package is intended for photo-documentation, and includes basic measuring and reporting tools. The NIS-Elements BR Microscope imaging software is geared for acquisition and device control for standard research applications, requiring four-dimensional imaging. Developed for standard research applications such as analysis and photodocumentation of fluorescent imaging, NIS-Elements BR features up to four-dimensional acquisition and advanced device control capabilities.

Nikon is also displaying the D-LEDI Fluorescence LED Illumination System, a long-lasting, multi-color light source for fluorescence observation. It is equipped with four LEDs (385 nm, 475 nm, 550 nm and 621 nm) to support commonly used fluorophores in fluorescence applications. The D-LEDI features a natural cooling system without the use of fans. This new design ensures a vibration-free, stable illumination source for all fluorescence imaging needs. Traditional mercury light sources require frequent lamp replacement. The D-LEDI features long-life LEDs (up to 20,000-hours) that eliminate this need.
 

Related Links:
Nikon Instruments 


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Original illustration showing how exposure-linked mutation patterns may influence tumor immune visibility (Photo courtesy of Máté Manczinger, HUN-REN Szeged BRC)

Cancer Mutation ‘Fingerprints’ to Improve Prediction of Immunotherapy Response

Cancer cells accumulate thousands of genetic mutations, but not all mutations affect tumors in the same way. Some make cancer cells more visible to the immune system, while others allow tumors to evade... Read more

Industry

view channel
Image: The initiative aims to speed next-generation diagnostic development during early pathogen emergence (photo courtesy of 123RF)

Cepheid Joins CDC Initiative to Strengthen U.S. Pandemic Testing Preparednesss

Cepheid (Sunnyvale, CA, USA) has been selected by the U.S. Centers for Disease Control and Prevention (CDC) as one of four national collaborators in a federal initiative to speed rapid diagnostic technologies... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.